LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006005.3:c.2452C>T
WFS1
· NP_005996.2:p.(Arg818Cys)
· NM_006005.3
GRCh37: chr4:6303974 C>T
·
GRCh38: chr4:6302247 C>T
Gene:
WFS1
Transcript:
NM_006005.3
Final call
VUS
PP3 supporting
Variant details
Gene
WFS1
Transcript
NM_006005.3
Protein
NP_005996.2:p.(Arg818Cys)
gnomAD AF
0.005068333723764286 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PP3 supporting was met because missense REVEL 0.758 exceeds the generic supporting threshold.
2
VUS: no pathogenic or benign rule was satisfied by the applied criteria.
Final determination:
Under generic ACMG/AMP 2015 fallback rules, one supporting criterion alone satisfies no pathogenic, likely pathogenic, likely benign, or benign combination, so the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not met | Not met: p.Arg818Cys is reported in one patient, but no previously established pathogenic same-amino-acid change is documented. |
PMID:26025012
PMID:25741868
|
| PS2 | Not assessed | Not assessed: no parental genotypes, maternity/paternity confirmation, or family-history data are reported for c.2452C>T (p.Arg818Cys). |
|
| PS3 | Not assessed | Not assessed: no variant-specific validated functional assay, assay control, or reproducible laboratory result is reported for WFS1 p.Arg818Cys. |
|
| PS4 | Not met | Not met: R818C was absent from 152 second-stage patients but present in one control, showing no affected-case enrichment and failing the PS4 OR >5.0 requirement. |
PMID:12605098
|
| PM1 | Not met | Not met: residue 818 has no documented critical-domain evidence or statistically significant hotspot, with Cancer Hotspots returning no result. |
hotspots
cosmic
PMID:25741868
|
| PM2 | Not met | Not met: gnomAD v4.1 total AF is 0.00506833, far above the generic PM2 supporting threshold of <=0.0001. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| PM3 | Not assessed | Not assessed: the variant was reported with p.Gly780Ala, but no parental testing or other evidence establishes trans phase or pathogenicity of the partner. |
PMID:26025012
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not met | Not met: no different missense variant at residue 818 has been determined pathogenic in the reviewed evidence. |
pm5_candidates
PMID:25741868
|
| PM6 | Not assessed | Not assessed: the variant is reported in one participant, but no parental testing or other de novo evidence is provided. |
|
| PP1 | Not assessed | Not assessed: zero affected-relative meioses or variant-specific co-segregation results are reported for c.2452C>T (p.Arg818Cys). |
|
| PP2 | Not assessed | Not assessed: WFS1 has 156/309 reported missense variants, but the required low benign-missense rate is not established. |
PMID:28432734
PMID:25741868
|
| PP3 | Met | Met at supporting strength: missense REVEL 0.758 meets the generic PP3 supporting threshold of >=0.644. |
revel
|
| PP4 | Not assessed | Not assessed: the exact-variant report gives no specific patient phenotype or family history demonstrating a single-etiology WFS1 disorder. |
PMID:26025012
|
| PP5 | Not met | Not met: ClinVar has zero expert-panel submissions for exact R818C, and the available laboratory classifications are not pathogenic or likely pathogenic expert-panel evidence. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00866652, below the generic BA1 threshold of 0.05 despite the higher Ashkenazi Jewish point estimate. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 0.00866652, below the generic BS1 threshold of 0.01; the Ashkenazi Jewish point estimate is not the permitted metric. |
gnomad_v2
gnomad_v4
PMID:28518168
PMID:25741868
|
| BS2 | Not assessed | Not assessed: gnomAD reports 35 homozygotes, but no individual age or phenotype data confirm healthy adults as required for BS2 in recessive Wolfram syndrome. |
gnomad_v2
gnomad_v4
PMID:12605098
PMID:11317350
|
| BS3 | Not assessed | Not assessed: no variant-specific validated assay demonstrates preserved WFS1 protein function or splicing for p.Arg818Cys. |
|
| BS4 | Not assessed | Not assessed: no affected family members with documented variant status are available to demonstrate lack of segregation. |
|
| BP1 | Not met | Not met: reported WFS1 variants include 156/309 missense versus 111/309 frameshift or nonsense variants, not primarily truncating disease variation. |
PMID:28432734
PMID:25741868
|
| BP2 | Not assessed | Not assessed: a second variant was reported, but its cis/trans phase and pathogenicity are not established, so BP2's allelic requirement remains unresolved. |
PMID:26025012
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: missense REVEL 0.758 exceeds the most permissive generic BP4 threshold of <=0.29. |
revel
|
| BP5 | Not assessed | Not assessed: R818C was reported with another WFS1 allele, but no separate molecular diagnosis or alternate disease basis was established. |
PMID:26025012
|
| BP6 | Not met | Not met: exact R818C has no ClinVar expert-panel classification, so ordinary benign or likely benign laboratory submissions cannot trigger BP6. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.